Compliance of private pharmacies in Uganda with controlled prescription drugs regulations: a mixed-methods study

Table 6 Predictors of compliance with CPD stock control requirements. Only professional and regulatory factors remained in the model after controlling for confounding

Factor	Category	Frequency (n)		χ²	Crude OR (95% CI)	p-value	Adjusted OR (95% CI)	p-value
Factor	Category	High compliance	Low compliance	χ²	Crude OR (95% CI)	p-value	Adjusted OR (95% CI)	p-value
Pharmacist is present in pharmacy premises	Yes	8	24	2.13	2.19 (0.75–6.33)	0.144	5.17 (1.30–20.57)	0.020
Pharmacist is present in pharmacy premises	No	9	59
MRA has ever invited us for a workshop on handling of narcotic drugs²	Yes	12	23	9.91	5.22 (1.75–15.54)	0.002	3.51 (1.03–11.92)	0.044
	No	6	60
MRA asked for returns of narcotic drug transactions²	Yes	13	25	11.17	6.03 (1.94–18.73)	0.001	1.93 (0.59–6.333	0.278
MRA asked for returns of narcotic drug transactions²	No	5	58
MRA has ever audited narcotic drugs in pharmacy²	Yes	12	27	7.27	4.15 (1.41–12.24)	0.007	5.11 (1.43–18.30)	0.012
MRA has ever audited narcotic drugs in pharmacy²	No	6	56

¹Pharmacy professional comprises pharmacists and pharmacy technicians; non-pharmacy professional comprises nurses, nursing assistants, assorted health professionals such as clinical officers (physician assistants) and orthopaedic officers, and one accounting/finance professional.²MRA, Medicines Regulatory Agency

ISSN: 1747-597X